Acacia Pharma Group Plc
Acacia Pharma Group Plc
  • Products
    • Overview
    • Therapeutic Areas
    • Marketed Products
    • APD403
  • Media
    • Press Releases
  • Investors
    • Overview
    • Regulatory Announcements
    • Shareholder Meetings
    • California Compliance statement
    • Contact
  • Contact
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • Site map
Acacia Pharma Group Plc
  • Products
    • Overview
    • Therapeutic Areas
    • Marketed Products
    • APD403
  • Media
    • Press Releases
  • Investors
    • Overview
    • Regulatory Announcements
    • Shareholder Meetings
    • California Compliance statement
    • Contact
  • Contact

Transforming medicine

Advancing care

Home > News > Press Releases

Press Releases

29 April 2022

Publication of Annual Report and Financial Statements for the Year ended 31 December 2021

30 March 2022

Acacia Pharma to Postpone Publication of its Results for the Full Year 2021, Scheduled on 31 March 2022

29 March 2022

Scheme of Arrangement Information Sheet

28 March 2022

Proposed Transaction with Eagle Pharmaceuticals, Inc. (Part 1 of 2)

28 March 2022

Proposed Transaction with Eagle Pharmaceuticals, Inc (Part 2 of 2)

  • 2022 (5)
Acacia Pharma Group Plc
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • Site map

© 2025 Acacia Pharma Group Plc

(Registered in England and Wales No: 09759376)
Registered office address: The Officers’ Mess, Royston Road, Duxford, Cambridge CB22 4QH, UK

Acacia Pharma Limited (Registered in England and Wales No: 05934843) and Acacia Pharma Inc (Incorporated under the laws of Delaware, No: 5799660) are members of the Acacia Pharma Group

Website by Instinctif Partners

By continuing to use acaciapharma.com you will be agreeing to the website Terms & Conditions, the Privacy Policy, and the use of Cookies.